MDSO: Medidata Solutions, Inc. - Summary | Jitta

Medidata Solutions, Inc.

NASDAQ:MDSO

Notice
Stock data is unavailable or the company’s delisted.
Price
$92.22
Loss Chance
49.4%
4.40JITTA SCORE
72.93%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (74)
Recent Business Performance (60)
Financial Strength (60)
Return to Shareholders (10)
Competitive Advantage (67)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Debt LevelLow Long Term Debt
Operating MarginDeclined
CapExVery High
Key Stats
Jitta Score
Jitta Line
4.40
72.93%
Health Care Technology
4.00
90.40%
7.49
96.12%
5.31
124.59%
COMPANY DESCRIPTION
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company’s platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company has a strategic collaboration with Mapi Research Trust. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York. As of October 28, 2019, Medidata Solutions, Inc. operates as a subsidiary of Dassault Systemes Americas Corp.